… (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 … -
RA DeFronzo, RE Ratner, J Han, DD Kim, MS Fineman, … - Diabetes Care, 2005 - Am Diabetes Assoc
... Group* Exenatide versus Insulin Glargine in Patients with Suboptimally ... page J. Hendry
FDA Approves Exenatide DOC News, July ... Home page Exenatide, a New Drug for ...
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes … -
DM Kendall, MC Riddle, J Rosenstock, D Zhuang, DD … - Diabetes Care, 2005 - Am Diabetes Assoc
... Group* Exenatide versus Insulin Glargine in Patients with Suboptimally ... page J. Hendry
FDA Approves Exenatide DOC News, July ... Home page Exenatide, a New Drug for ...
… for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients -
O Lingjaerde, UG Ahlfors, P Bech, SJ Dencker, K … - Acta Psychiatrica Scandinavica, 1987 - Blackwell Synergy
... A new comprehensive rating scale for ... This means that the treating doc- tor must always
try to ... unwanted effects, for the best possible benefit to the patient. ...
[CITATION] " Patient informatics": creating new partnerships in medical decision making. -
SA Bader, RM Braude - ACADEMIC MEDICINE, 1998
... MD, Associate Editor "Patient Informatics": Creating New Partnerships in ... call the
shots, along with their doc- tors ... Patients are more aware than they have been ...
A new approach to the measurement of quality of life. The Patient-Generated Index -
DA Ruta, AM Garratt, M Leng, IT Russell, LM … - Med Care, 1994 - JSTOR
... validity (the extent to which a new measure is ... for monitoring quality-of- life
improvements in individual patients. ... life listed in stage one, the doc- tor may ...
Online patient-helpers and physicians working together: a new partnership for high quality health … -
T Ferguson - BMJ, 2000 - pubmedcentral.nih.gov
... helpers and physicians working together: a new partnership for ... 7. Ferguson T. From
doc-providers to coach-consultants ... type 2 provider-patient relationships. ...
A taxonomy of requests by patients (TORP): a new system for understanding clinical negotiation in … -
RL Kravitz, RA Bell, CE Franz - J Fam Pract, 1999 - jfponline.com
... length (in minutes), and visit type (new, follow-up ... RIAS and DOC are validated systems,
but neither was specifically intended to examine patients? requests ...
-
… with cisplatin (cis) or gemcitabine (gem) in stage IV non-small-cell lung cancer (NSCLC) patients ( … -
R Rosell, M Cobo, D Isla, B Massuti, A Montes, L … - Journal of Clinical Oncology, 2005 - asco.org
... of gemcitabine (gem)/cisplatin (cis)- vs docetaxel (doc)/cis-treated ... come of age
in selecting patients for lung ... Rafael Rosell, MD, PhD Session: New Biology of ...
Doxorubicin With Cyclophosphamide Followed by Docetaxel Every 21 Days Compared With Doxorubicin and … -
G von Minckwitz, G Raab, A Caputo, M Schutte, J … - Journal of Clinical Oncology, 2005 - jco.ascopubs.org
... View larger version (47K): [in this window] [in a new window], Fig 1. Progress of
patients through the study. AC-DOC, sequential schedule of doxorubicin and ...
NEW FINDINGS IN APPARENT MINERALOCORTICOID EXCESS -
… , E STONER, K MARTIN, JW BALFE, PA JOSE, MI NEW - Clinical Endocrinology, 1987 - Blackwell Synergy
... Pediatric Clinical Research Center at The New York Hospital ... and informed consent
was obtained from the patients. ... plasma renin, undetec- table DOC and aldosterone ...
Source: Google Scholar |